Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Developing Acetyl-Click Assay for HAT1 Inhibitor Screening
Published on: January 26, 2024
In vitro acetyltransferase activity assays for N-terminal acetyltransferases
Taining Li1, David C Schultz2, Ronen Marmorstein1
1Department of Biochemistry and Biophysics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States; Abramson Family Cancer Research Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.
Abstract:
N-terminal acetyltransferases (NATs) mediate co- and post-translational N-terminal protein acetylation to mediate essential protein functions, and their altered activities are linked to several diseases. Because of this connection of NATs to normal and abnormal cellular function, it is important to have assays available to evaluate NAT activity in vitro. This chapter outlines three in vitro assays for studying NAT activity: a sensitive radioactive method, and a scalable fluorescence-based approach and luminescence-coupled assay compatible with high-throughput screening. Using human NatB as a model NAT, we compare assay performance, highlighting differences in sensitivity, substrate requirements, and inhibitor detection. These methods enable investigations and support the development of NAT-targeted therapeutics, thus highlighting their utility in basic research and drug discovery.

